Ella L. Kim

Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase

Juliya Kalinina, Jun Young Ahn, Narra S. Devi et al. · Clinical Cancer Research · 2016 · 72 citations

Medicine, Biochemistry, Oncology +15

Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma

Ella L. Kim, Maxim Sorokin, Sven Rainer Kantelhardt et al. · Cancers · 2020 · 66 citations · Full text

Medicine, Cancer Biology, Oncology +17

Thromboxane synthase regulates the migratory phenotype of human gliomacells

Alf Giese, Christian Hagel, Ella L. Kim et al. · Neuro-Oncology · 1999 · 54 citations · Full text

Medicine, Molecular Biology, Oncology +15

CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells

Alonso Barrantes‐Freer, Mirjam Renovanz, Marcus Eich et al. · PLoS ONE · 2015 · 44 citations · Full text

Medicine, Cell Biology, Oncology +17

Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells

Amanda Tivnan, Tatjana Heilinger, Joanne M. Ramsey et al. · Oncotarget · 2017 · 38 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmacology +17